Topiramate Tablet, Film Coated
Product Images NDC 68462-110

8 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68462-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Topiramate, showing its molecular framework with oxygen, carbon, nitrogen, and sulfur atoms arranged in a cyclic sulfate ester with several methyl groups and an amino substituent.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A cumulative incidence plot showing cumulative rates for time to first seizure over days up to 500, comparing Topiramate 50 mg/day (solid line) and Topiramate 400 mg/day (dashed line) for patient groups of 234 and 238 respectively. The graph indicates lower seizure incidence for the 400 mg/day group, with a p-value of 0.0002.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A bar chart comparing change from baseline to double-blind phase in average monthly migraine period rate for Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day versus placebo. Two studies are shown (Study 10 in black and Study 11 in gray) with sample sizes indicated. The chart shows greater reduction in migraine rate with increasing Topiramate dose, with statistically significant differences noted at 100 mg/day and 200 mg/day doses.*
FDA Label Image
FDA Label Image

Label25mg60 (Label25mg60)

Label25mg60 (Label25mg60)
Topiramate 25 mg film-coated tablets label showing a 60-tablet bottle. The label states 'Topiramate Tablets, USP 25 mg' with usage and storage instructions, caution for prescription verification, and the Glenmark Pharmaceuticals Inc., USA labeler information. The NDC code is 68462-108-60.*
FDA Label Image

Label50mg60 (Label50mg60)

Label50mg60 (Label50mg60)
Topiramate Tablets USP 50 mg film-coated tablets label with NDC 68462-153-60 by Glenmark Pharmaceuticals Inc., USA. The label includes prescription cautions, pharmacist dispensing instructions, storage conditions, medication guide availability, and distributor information. The package contains 60 tablets for oral use.*
FDA Label Image

Label100mg60 (Label100mg60)

Label100mg60 (Label100mg60)
Topiramate Tablets, USP 100 mg film-coated tablets label for oral use. The label shows a 60-tablet prescription package distributed by Glenmark Pharmaceuticals Inc., USA. It includes storage instructions, cautions to verify prescriptions, and a barcode alongside contact information for Glenmark Pharmaceuticals.*
FDA Label Image

Label200mg60 (Label200mg60)

Label200mg60 (Label200mg60)
Topiramate Tablets USP 200 mg film-coated tablets package label for oral use. The label from Glenmark Pharmaceuticals Inc., USA, indicates a prescription-only drug with a package count of 60 tablets. It includes a caution to verify the prescription before dispensing and instructions for pharmacists to provide the medication guide separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.